Dr. Anudeep J. Surendranath, MD

Dr. Surendranath practices at CHI St Vincent Hot Springs in Hot Springs National Park, Arkansas.

Dr. Surendranath's NPI, 1346655511, was assigned on June 26, 2014. Dr. Surendranath holds Arkansas license E-13086.

Dr. Surendranath's primary practice is CHI St Vincent Hot Springs, at 300 Werner St, Hot Springs National Park, AR 71913 in Garland County. The practice phone is (501) 622-1000.

Dr. Surendranath's primary practice is CHI St Vincent Hot Springs in Hot Springs National Park, Arkansas. Dr. Surendranath is also affiliated with CHI St. Vincent Hot Springs. The medical group on file is CHI St. Vincent Primary Care - Glenwood. Dmand AI also links Dr. Surendranath to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Surendranath practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Surendranath's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Surendranath's licenses on file in 2 states: Arkansas and Michigan.

CMS data shows 492 Medicare services from Dr. Surendranath across 5 procedure codes in 2024, for 249 Medicare patients. Medicare paid $41,754 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 249 Medicare patients who saw Dr. Surendranath in 2024. The largest group is 75 to 84, with 97 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Surendranath's median patient age at 72, with 61% women.

In 2024, Dr. Surendranath wrote 34 Medicare Part D claims for 12 patients. 97% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $309 in total drug cost. In 2023, CMS named 191 claims across 10 drugs.

Dr. Surendranath accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Surendranath, published from 2024 to 2025. 2025 was the busiest year, with 3. Dr. Surendranath has published most often in Neurol Int. Dr. Surendranath's most frequent co-authors are Rahul Khanna, MD, Saurabh Jagdishbhai Singhal, MD and Tanu Garg, MD.

CMS Open Payments shows 165 general payments to Dr. Surendranath from 22 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 72% of the total. Ipsen Innovation paid the most, $1,307.